Annual D&A
$19.26 M
-$2.98 M-13.38%
December 1, 2024
Summary
- As of March 12, 2025, ADPT annual depreciation & amortization is $19.26 million, with the most recent change of -$2.98 million (-13.38%) on December 1, 2024.
- During the last 3 years, ADPT annual D&A has risen by +$5.30 million (+38.01%).
- ADPT annual D&A is now -13.38% below its all-time high of $22.23 million, reached on December 31, 2023.
Performance
ADPT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$4.45 M
-$143.00 K-3.11%
December 1, 2024
Summary
- As of March 12, 2025, ADPT quarterly depreciation & amortization is $4.45 million, with the most recent change of -$143.00 thousand (-3.11%) on December 1, 2024.
- Over the past year, ADPT quarterly D&A has dropped by -$143.00 thousand (-3.11%).
- ADPT quarterly D&A is now -22.82% below its all-time high of $5.76 million, reached on September 30, 2023.
Performance
ADPT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$19.26 M
-$944.00 K-4.67%
December 1, 2024
Summary
- As of March 12, 2025, ADPT TTM depreciation & amortization is $19.26 million, with the most recent change of -$944.00 thousand (-4.67%) on December 1, 2024.
- Over the past year, ADPT TTM D&A has dropped by -$944.00 thousand (-4.67%).
- ADPT TTM D&A is now -13.38% below its all-time high of $22.23 million, reached on December 31, 2023.
Performance
ADPT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ADPT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.4% | -3.1% | -4.7% |
| 3 y3 years | +38.0% | -14.4% | +3.4% |
| 5 y5 years | +147.2% | -14.4% | +3.4% |
ADPT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.4% | +38.0% | -22.8% | at low | -13.4% | +38.0% |
| 5 y | 5-year | -13.4% | +147.2% | -22.8% | +124.9% | -13.4% | +147.2% |
| alltime | all time | -13.4% | +232.2% | -22.8% | +206.6% | -13.4% | +1227.1% |
Adaptive Biotechnologies Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $19.26 M(-13.4%) | $4.45 M(-3.1%) | $19.26 M(-4.7%) |
| Sep 2024 | - | $4.59 M(-8.2%) | $20.20 M(-5.5%) |
| Jun 2024 | - | $5.00 M(-4.0%) | $21.37 M(-3.0%) |
| Mar 2024 | - | $5.21 M(-3.3%) | $22.02 M(-0.9%) |
| Dec 2023 | $22.23 M(+6.3%) | $5.39 M(-6.4%) | $22.23 M(+0.5%) |
| Sep 2023 | - | $5.76 M(+1.9%) | $22.13 M(+1.7%) |
| Jun 2023 | - | $5.65 M(+4.2%) | $21.75 M(+2.2%) |
| Mar 2023 | - | $5.42 M(+2.6%) | $21.29 M(+1.8%) |
| Dec 2022 | $20.92 M(+49.9%) | $5.29 M(-1.8%) | $20.92 M(+2.1%) |
| Sep 2022 | - | $5.38 M(+3.6%) | $20.48 M(+10.0%) |
| Jun 2022 | - | $5.20 M(+2.7%) | $18.63 M(+14.0%) |
| Mar 2022 | - | $5.06 M(+4.3%) | $16.34 M(+17.1%) |
| Dec 2021 | $13.95 M | $4.85 M(+37.4%) | $13.95 M(+21.8%) |
| Sep 2021 | - | $3.53 M(+21.4%) | $11.46 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $2.90 M(+8.8%) | $10.07 M(+9.9%) |
| Mar 2021 | - | $2.67 M(+13.6%) | $9.16 M(+8.2%) |
| Dec 2020 | $8.47 M(+8.7%) | $2.35 M(+9.7%) | $8.47 M(+3.4%) |
| Sep 2020 | - | $2.14 M(+7.3%) | $8.20 M(+1.0%) |
| Jun 2020 | - | $2.00 M(+1.0%) | $8.11 M(+1.6%) |
| Mar 2020 | - | $1.98 M(-4.7%) | $7.99 M(+2.5%) |
| Dec 2019 | $7.79 M(+29.8%) | $2.08 M(+0.6%) | $7.79 M(+6.6%) |
| Sep 2019 | - | $2.06 M(+10.3%) | $7.31 M(+8.9%) |
| Jun 2019 | - | $1.87 M(+4.9%) | $6.71 M(+6.0%) |
| Mar 2019 | - | $1.78 M(+11.9%) | $6.33 M(+5.5%) |
| Dec 2018 | $6.00 M(+3.5%) | $1.59 M(+8.7%) | $6.00 M(+36.1%) |
| Sep 2018 | - | $1.47 M(-1.7%) | $4.41 M(+49.8%) |
| Jun 2018 | - | $1.49 M(+2.8%) | $2.94 M(+102.8%) |
| Mar 2018 | - | $1.45 M | $1.45 M |
| Dec 2017 | $5.80 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual depreciation & amortization?
- What is the all time high annual D&A for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual D&A year-on-year change?
- What is Adaptive Biotechnologies quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly D&A year-on-year change?
- What is Adaptive Biotechnologies TTM depreciation & amortization?
- What is the all time high TTM D&A for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM D&A year-on-year change?
What is Adaptive Biotechnologies annual depreciation & amortization?
The current annual D&A of ADPT is $19.26 M
What is the all time high annual D&A for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual depreciation & amortization is $22.23 M
What is Adaptive Biotechnologies annual D&A year-on-year change?
Over the past year, ADPT annual depreciation & amortization has changed by -$2.98 M (-13.38%)
What is Adaptive Biotechnologies quarterly depreciation & amortization?
The current quarterly D&A of ADPT is $4.45 M
What is the all time high quarterly D&A for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly depreciation & amortization is $5.76 M
What is Adaptive Biotechnologies quarterly D&A year-on-year change?
Over the past year, ADPT quarterly depreciation & amortization has changed by -$143.00 K (-3.11%)
What is Adaptive Biotechnologies TTM depreciation & amortization?
The current TTM D&A of ADPT is $19.26 M
What is the all time high TTM D&A for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM depreciation & amortization is $22.23 M
What is Adaptive Biotechnologies TTM D&A year-on-year change?
Over the past year, ADPT TTM depreciation & amortization has changed by -$944.00 K (-4.67%)